期刊名称：EXPERIMENTAL AND MOLECULAR PATHOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.
Research Areas include:
*Stem cells
* Neoangiogenesis
* Molecular diagnostics
* Polymerase chain reaction
* In situ hybridization
* DNA sequencing
* Cell receptors
* Carcinogenesis
* Pathobiology of neoplasia
* Complex infectious diseases
* Transplantation
* Cytokines
* Flow cytomeric analysis
* Inflammation
* Cellular injury
* Immunology and hypersensitivity
* Athersclerosis
Instructions to Authors
Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal has a broad scope, publishing both cellular- and molecular-level research and giving additional special impetus to molecular diagnostics and to immunopathology. Among the subjects targeted for major emphasis are atherosclerosis, cell receptors, carcinogenesis, complex infectious diseases, cytogenetics, flow cytometric analysis, hemostasis and thrombosis, cellular injury, oncogenes, pathogenesis of infection, tumor immunology, immunopathology, transplantation biology, macrophages, and cytokines, among other research topics. The journal also publishes selected interpretive synthesis reviews by bench-level investigators working at the cutting edge of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of nature's most jealously guarded secrets on the pathologic basis of disease.
Submission of Manuscripts
Manuscripts must be written in English and should be submitted in triplicate (one original and two photocopies), including three sets of good-quality figures, to
Dr. Julius M. Cruse
Immunopathology Section
Department of Pathology
University of Mississippi Medical Center
2500 North State Street
Jackson, MS 39216-4505, USA
There are no submission fees or page charges. Each manuscript should be accompanied by a letter outlining the basic findings of the paper and their significance.
Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out; further, that any person cited as a source of personal communications has approved such citation. Written authorization may be required at the Editor's discretion. Articles and any other material published in Experimental and Molecular Pathology represent the opinions of the author(s) and should not be construed to reflect the opinions of the Editor(s) and the Publisher. Manuscripts that do not meet the general criteria or standards for publication in Experimental and Molecular Pathology will be immediately returned to the authors, without detailed review.
Upon acceptance of an article, authors will be asked to transfer copyright (for more information on copyright, see http://authors.elsevier.com). This transfer will ensure the widest possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the manuscript. A form facilitating transfer of copyright will be provided.
If material from other copyrighted works is included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier.com.
Electronic Transmission of Accepted Manuscripts. Authors are requested to transmit the text and art of the manuscript in electronic form, via computer disk or e-mail after all revisions have been incorporated and the manuscript has been accepted for publication. Submission as an e-mail attachment is acceptable provided that all files are included in a single archive the size of which does not exceed 2 megabytes (emp@elsevier.com). The manuscript will be edited according to the style of the journal, and authors must read the proofs carefully.
Preparation of Manuscripts
All abbreviations, chemical names, and journal names should follow the style of Chemical Abstracts Service Source Index. Use generic names of chemicals wherever possible. Proprietary names and trademarks should appear only to identify the source of the chemical and subsequently only the generic name should be used. All abbreviations should be unpunctuated. A useful writing guide is the "CBE Style Manual" published by the Council of Biology Editors.
Manuscripts should be double-spaced throughout on one side of 8.5 x 11-inch or A4 white paper with 1-inch margins on all sides. Pages should be numbered consecutively and organized as follows:
The title page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers). The title should be limited to 15 words or 80 characters.
The abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in 150?200 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.
The Introduction should be as concise as possible, without subheadings.
Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.
Results and Discussion may be combined and may be organized into subheadings.
Acknowledgments should be brief and should precede the references.
References should be cited in the text by author's name and year of publication in parentheses. Journal names should follow the style of Chemical Abstracts Service Source Index. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text. References should be listed alphabetically. Please note the following examples:
Hagag, N., Viola, M.V., 1993. Chromosome Microdissection and Cloning: A Practical Guide. Academic Press, San Diego.
Reichert, U., Michel, S., Schmidt, R., 1993. The cornified envelope: a key structure of terminally differentiating keratinocytes. In: Darmon, M., Blumenberg, M. (Eds.),Molecular Biology of the Skin: The Keratinocyte. Academic Press, San Diego, pp. 107-150.
Wali, A., Strayer, D.S., 1999. Comparative effects of virulent and avirulent poxviruses on cell cycle progression. Exp. Mol. Pathol. 66, 31-38.
References in foreign languages should appear in the language of the original paper.
Figures should be in a finished form suitable for publication and understandable even without reading the text. Every figure should have a legend. Number figures consecutively with Arabic numerals, and indicate the top and the authors on the back of each figure. Lettering on drawings should be of professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.
Color Figures. Illustration in color can be accepted only if the authors defray the cost. Color figures for exclusive use as cover illustrations may be submitted by authors who are also submitting a manuscript for consideration. These figures do not need to relate to the manuscript being submitted but should relate to the larger scope and focus of Experimental and Molecular Pathology.
Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below. Authors should submit complex tables as camera-ready copy.
Proofs will be sent to the corresponding author. To avoid delay in publication, only necessary changes should be made, and proofs should be returned promptly. Authors will be charged for alterations that exceed 10% of the total cost of composition.
Editorial Board
-
- Editor-in-Chief
- J.M. Cruse, Mississippi, USA
- Deputy Editor-in-Chief:
- R.E. Lewis, Mississippi, USA
- Senior Editor:
- M.I. Greene, Pennsylvania, USA
- Founding Editor:
- F. Coulston, New Mexico, USA
- Editorial Board:
- K. Boekelheide, Toxicologic Pathology, Rhode Island, USA
M. Buja, Cardiovascular Pathology, Texas, USA
Y. Choi, Immunology, Pennsylvania, USA
R.B. Colvin, Anatomic Pathology and Immunopathology, Massachusetts, USA
D.S. Dimitrov, Retrovirology and AIDS, Maryland, USA
E. Farber, Carcinogeneses, Pennsylvania, USA
K. Hirokawa, Aging, Tokyo, Japan
A.B. Jenson, Herpesvirus Pathology, Washington DC, USA
J. Kant, Molecular and Cellular Pathology, Pennsylvania, USA
D. Kaufman, Carcinogenesis, North Carolina, USA
J.D. Kemp, Molecular Pathology, Iowa, USA
C.J. Kirkpatrick, Molecular Pathology, Mainz, Germany
P. Kleiheus, Neuropathology, Lyon, France
R.L. Kradin, Immunopathology, Massachusetts, USA
C. Kuhn, Pulmonary Pathology, Rhode Island, USA
S.L. Kunkel, Molecular and Cellular Pathology, Michigan, USA
D. Longnecker, Neoplasia, New Hampshire, USA
R.G. Lynch, Immunopathology, Iowa, USA
H.F.L. Mark, Cytogenetics, Rhode Island, USA
G.E. Marti, Hematology, Maryland, USA
J. Martin, Complex Infectious Diseases, California, USA
W.J. Mergner, Atherosclerosis, Marlyand, USA
P.M. Newberne, Anatomic Pathology, Massachusetts, USA
M. Potter, Neoplasia, Maryland, USA
M. Prystowsky, Anatomic Pathology, New York, USA
N.R. Rose, Immunopathology, Maryland, USA
H.S. Rosenberg, Pediatric Pathology, Texas, USA
A. Rostami, Neuropathology, Pennsylvania, USA
A.P. Sanfilippo, Transplantation Immunology, Maryland, USA
T. Shirai, Molecular and Cellular Pathology, Tokyo, Japan
H. Shulman, Bone Marrow Transplantation, Washintgon, USA
L. Silberstein, Molecular and Cellular Pathology, Pennsylvania, USA
A. Sirica, Pathobiology of Neoplasia, Virginia, USA
B.F. Trump, Toxicologic Pathology, Maryland, USA
G. Tsongalis, Molecular Pathology, Connecticut, USA
S. Vandenberg, Neuropathology, Virginia, USA
P.A. Ward, Inflammation, Michigan, USA
T. Yoshiki, Molecular and Cellular Pathology, Sapporo, Japan
E.D. Zanjani, Hematopathology, Nevada, USA
M. Zeitz, Mucosal Immunology, Homburg/Saar
|
